Skin Treatment (Pharmacies) - Spain

  • Spain
  • Revenue in the Skin Treatment market is projected to reach US$231.60m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 5.69%, resulting in a market volume of US$289.00m by 2028.
  • In global comparison, most revenue will be generated in the United States (US$3,319.00m in 2024).
  • In relation to total population figures, per person revenues of US$4.88 are generated in 2024.

Key regions: Canada, United States, France, Europe, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Skin Treatment (Pharmacies) market in Spain has experienced significant growth in recent years, driven by changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Skin Treatment (Pharmacies) market have shifted towards natural and organic products. Consumers are becoming more conscious about the ingredients used in skincare products and are opting for products that are free from harmful chemicals. This preference for natural and organic products is a global trend, driven by increasing awareness about the potential health risks associated with synthetic ingredients. In Spain, this trend is further fueled by the country's rich tradition of using natural remedies and botanical extracts for skincare. One of the key trends in the Skin Treatment (Pharmacies) market in Spain is the growing demand for anti-aging products. As the population ages, there is a greater emphasis on maintaining youthful and healthy-looking skin. This trend is not unique to Spain, as it is observed worldwide. However, in Spain, there is a cultural emphasis on appearance and maintaining a youthful appearance, which further drives the demand for anti-aging skincare products. Another trend in the market is the increasing popularity of online sales channels. With the rise of e-commerce, consumers are now able to purchase skincare products from the comfort of their own homes. This convenience factor, coupled with competitive pricing and a wide range of product options, has led to a significant increase in online sales in the Skin Treatment (Pharmacies) market in Spain. This trend is in line with the global shift towards online shopping in various industries. In addition to customer preferences and emerging trends, local special circumstances also play a role in the development of the Skin Treatment (Pharmacies) market in Spain. The country has a strong pharmacy network, with pharmacies being a common point of access for skincare products. Pharmacies in Spain are well-regulated and offer a wide range of skincare products, including prescription medications. This accessibility and trust in the pharmacy channel contribute to the growth of the market. Furthermore, Spain is a popular tourist destination, attracting millions of visitors each year. The tourism industry plays a significant role in the skincare market, as tourists often purchase skincare products as souvenirs or for personal use. This influx of tourists contributes to the overall growth of the Skin Treatment (Pharmacies) market in Spain. Underlying macroeconomic factors also influence the development of the market. Spain has experienced economic recovery in recent years, with increasing disposable incomes and consumer confidence. As a result, consumers are more willing to spend on skincare products, driving the growth of the market. Additionally, the skincare market is less affected by economic downturns compared to other industries, as skincare is considered a necessity rather than a luxury. In conclusion, the Skin Treatment (Pharmacies) market in Spain is developing due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards natural and organic products, the growing demand for anti-aging products, the popularity of online sales channels, the strong pharmacy network, the influence of the tourism industry, and the economic recovery in Spain all contribute to the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)